Forte Biosciences Inc (FBRX) — Strategic Asset Allocation Index
Forte Biosciences Inc (FBRX) has a Strategic Asset Allocation Index of 0.1% as of June 2021. Strategic assets (PP&E of $70.00K plus long-term investments of $-) total $70.00K, measured against net assets of $49.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Forte Biosciences Inc Strategic Asset Allocation Index (2015–2020)
This chart shows how Forte Biosciences Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the index stands at 0.1%, representing strategic assets of $70.00K against net assets of $49.91 Million USD. Explore how efficiently does Forte Biosciences Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Forte Biosciences Inc (2015–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Forte Biosciences Inc from 2015 to 2020, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Forte Biosciences Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 0.2% | $97.00K | $97.00K | $- | $58.98 Million | ▼ -2.5 pp |
| 2019 | 2.6% | $152.00K | $152.00K | $- | $5.75 Million | ▼ -4.2 pp |
| 2018 | 6.8% | $3.97 Million | $3.97 Million | $- | $58.15 Million | ▲ +5.1 pp |
| 2017 | 1.7% | $1.22 Million | $1.22 Million | $- | $71.08 Million | ▼ -8.9 pp |
| 2016 | 10.6% | $743.00K | $743.00K | $- | $7.00 Million | ▲ +9.5 pp |
| 2015 | 1.1% | $445.00K | $445.00K | $- | $39.08 Million | — |